AC Immune (NASDAQ: ACIU)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.240 | -0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AC Immune (NASDAQ: ACIU) through any online brokerage.
There are no as such competitors for AC Immune.
The latest price target for AC Immune (NASDAQ: ACIU) was reported by SVB Leerink on Monday, December 20, 2021. The analyst firm set a price target for 15.00 expecting ACIU to rise to within 12 months (a possible 343.79% upside). 1 analyst firms have reported ratings in the last year.
The stock price for AC Immune (NASDAQ: ACIU) is $3.38 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for AC Immune.
AC Immune’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for AC Immune.
AC Immune is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.